ABSTRACT A recording of ≥ 30 seconds is required to diagnose paroxysmal atrial fibrillation when using ambulatory ECG monitoring. It is unclear if shorter runs are relevant with regards to stroke risk.
Methods An online survey of cardiologists and stroke physicians was carried out to assess current management of patients with short runs of atrial arrhythmia within Europe.
Results Respondents included 311 clinicians from 32 countries. To diagnose atrial fibrillation, 80% accepted a single 12-lead ECG and 36% accepted a single run of < 30 seconds on ambulatory monitoring. Stroke physicians were twice as likely to accept < 30 seconds of arrhythmia as being diagnostic of atrial fibrillation (OR 2.43, 95% CI 1.19–4.98). They were also more likely to advocate anticoagulation for hypothetical patients with lower risk; OR 1.9 (95% CI 1.0–3.5) for a patient with CHA2DS2-VASc = 2.
Conclusion Short runs of atrial fibrillation create a dilemma for physicians across Europe. Stroke physicians and cardiologists differ in their diagnosis and management of these patients.
CammAJ, KirchhofP, LipGYH. Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J2010; 31: 2369–429. https://dx-doi-org.web.bisu.edu.cn/10.1093/eurheartj/ehq278
KochhäuserS, DecheringDG, DittrichR. Supraventricular premature beats and short atrial runs predict atrial fibrillation in continuously monitored patients with cryptogenic stroke. Stroke2014; 45: 884–6. https://dx-doi-org.web.bisu.edu.cn/10.1161/STROKEAHA.113.003788
7.
RankinAJ, TranRT, Abdul-RahimAH. Clinically important atrial arrhythmia and stroke risk: a UK-wide online survey among stroke physicians and cardiologists. QJM2014; 107: 895–902. https://dx-doi-org.web.bisu.edu.cn/10.1093/qjmed/hcu177
8.
McHughM. Interrater reliability: the kappa statistic. Biochem Med2012; 22: 276–82.
9.
BorianiG, GlotzerTV, SantiniM. Device-detected atrial fibrillation and risk for stroke: an analysis of >10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices). Eur Heart J2014; 35: 508–16. https://dx-doi-org.web.bisu.edu.cn/10.1093/eurheartj/eht491
DaoudEG, GlotzerTV, WyseDG. Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: A subgroup analysis of TRENDS. Heart Rhythm2011; 8: 1416–23. https://dx-doi-org.web.bisu.edu.cn/10.1016/j.hrthm.2011.04.022
MartinDT, BersohnMM, WaldoAL. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J2015; 36: 1660–8. https://dx-doi-org.web.bisu.edu.cn/10.1093/eurheartj/ehv115
14.
AlhadramyO, JeerakathilTJ, MajumdarSR. Prevalence and predictors of paroxysmal atrial fibrillation on Holter monitor in patients with stroke or transient ischemic attack. Stroke2010; 41: 2596–600. https://dx-doi-org.web.bisu.edu.cn/10.1161/STROKEAHA.109.570382
SposatoLA, CiprianoLE, RiccioPM. Very short paroxysms account for more than half of the cases of atrial fibrillation detected after stroke and TIA: a systematic review and meta- analysis. Int J Stroke2015; 10: 801–7. https://dx-doi-org.web.bisu.edu.cn/10.1111/ijs.12555
17.
DienerH-C, EastonJD, GrangerCB. Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS). Int J Stroke2015; 10: 1309–12. https://dx-doi-org.web.bisu.edu.cn/10.1111/ijs.12630
